AMP PD - sporedata/researchdesigneR GitHub Wiki

General description

The Accelerating Medicines Partnership – Parkinson's Disease (AMP-PD) initiative is a collaborative effort involving both public and private sectors, established to discover and confirm diagnostic and predictive markers and indicators of disease progression for Parkinson's Disease. It also seeks to enhance the design of clinical trials and aid in discovering new therapeutic pathways.

To achieve these objectives, AMP-PD has synchronized longitudinal clinical data from seven extensive existing cohorts and undertaken comprehensive genomic sequencing, ongoing transcriptomic, and proteomic studies, utilizing available samples of blood, cerebrospinal fluid (CSF), and brain tissue.

In summary, AMP-PD's primary focus is discovering and validating the most promising biological targets for drug development. At its inception, the disease areas encompassed by AMP included Alzheimer's disease, type 2 diabetes, autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus (lupus)), and Parkinson's disease.

Related publications

Data access

More information about NSRR can be found at https://amp-pd.org/

To access NSRR data, visit https://amp-pd.org/data/summary-data-dashboard